OXFORD DRUG DESIGN LTD has a total of 19 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are LINZ GUENTER, BACON EDWARD R and BERGNES GUSTAVE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Israel | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Mexico | 2 | |
#8 | China | 1 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Charlton Michael | 12 |
#2 | Jirgensons Aigars | 12 |
#3 | Loza Einars | 12 |
#4 | Finn Paul William | 12 |
#5 | Edmund Grace | 7 |
#6 | Paul William Finn | 5 |
#7 | Einars Loza | 5 |
#8 | Ribas De Pouplana Lluis | 5 |
#9 | Michael Charlton | 5 |
#10 | Aigars Jirgensons | 5 |
Publication | Filing date | Title |
---|---|---|
WO2018065611A1 | 2-amino-n-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-trna synthetase | |
CA2975682A1 | Novel n-acyl-arylsulfonamide derivatives as aminoacyl-trna synthetase inhibitors |